Medifast Share Price (NYSE: MED)

$14.04

▲

0.02

(0.14%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Medifast Stock chart to analyse performance

Medifast stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$14.02
Today's High:$14.21
$14.04
0.14%
Downside
Day's Volatility :1.34%
Upside
1.2%
52 Weeks Low:$11.57
52 Weeks High:$21.98
$14.04
17.6%
Downside
52 Weeks Volatility :47.36%
Upside
36.12%

Medifast Stock Returns

Period	Medifast Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	5.48%	-2.5%	0.0%
6 Months	0.21%	-2.8%	0.0%
1 Year	-21.68%	-2.1%	0.0%
3 Years	-88.17%	9.8%	-4.7%

Medifast Inc Key Stats

Check Medifast key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$14.02
Open	$14.21
Today's High	$14.21
Today's Low	$14.02
Market Capitalization	$154.2M
Today's Volume	$118.9K
52 Week High	$21.98
52 Week Low	$11.5692
Revenue TTM	$480.4M
EBITDA	$26.7M
Earnings Per Share (EPS)	$0.33
PE Ratio	42.52
Profit Margin	0.76%
Quarterly Earnings Growth YOY	-0.87%
Return On Equity TTM	1.73%

Stock Returns calculator for Medifast Stock including INR - Dollar returns

The Medifast stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Medifast investment value today

Current value as on today

₹83,545

Returns

₹16,455

(-16.46%)

Returns from Medifast Stock

₹21,739 (-21.74%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Medifast Stock

21%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Medifast Stock from India on INDmoney has increased by 21% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Medifast Inc

Name
Holdings %
Name
Holdings %
BlackRock Inc
8.64%
Renaissance Technologies Corp
8.09%
Vanguard Group Inc
7.42%
Charles Schwab Investment Management Inc
3.83%
Acadian Asset Management LLC
3.51%
D. E. Shaw & Co LP
2.92%

Analyst Recommendation on Medifast Stock

Rating

Trend

Sell

0%Buy

44%Hold

55%Sell

Based on 9 Wall street analysts offering stock ratings for Medifast(by analysts ranked 0 to 5 stars)

Medifast Share Price Target

What analysts predicted

Upside of 6.84%

Target:

$15.00

Current:

$14.04

Medifast share price target is $15.00, a slight Upside of 6.84% compared to current price of $14.04 as per analysts' prediction.

Medifast Stock Insights

Price Movement
In the last 3 years, MED stock has moved down by -88.9%
Decreasing Revenue
Revenue is down for the last 10 quarters, 348.98M → 105.55M (in $), with an average decrease of 12.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -772.0K → 2.48M (in $), with an average increase of 131.1% per quarter
MED vs FTDR (1 yr)
In the last 1 year, Frontdoor Inc has given 26.5% return, outperforming this stock by 49.7%
MED vs FTDR (3 yr)
In the last 3 years, Frontdoor Inc has given 158.1% return, outperforming this stock by 247.0%
Price to Sales
ForMED every $1 of sales, investors are willing to pay $0.3, whereas for Frontdoor Inc, the investors are paying $2.3 for every $1 of sales.

Medifast Inc Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$713.7M	↑ 42.45%
Net Income	$77.9M	↑ 39.66%
Net Profit Margin	10.92%	↓ 0.22%

	FY20	Y/Y Change
Revenue	$934.8M	↑ 30.99%
Net Income	$102.9M	↑ 32.01%
Net Profit Margin	11.0%	↑ 0.08%

	FY21	Y/Y Change
Revenue	$1.5B	↑ 63.25%
Net Income	$164.0M	↑ 59.47%
Net Profit Margin	10.75%	↓ 0.25%

	FY22	Y/Y Change
Revenue	$1.6B	↑ 4.75%
Net Income	$143.6M	↓ 12.48%
Net Profit Margin	8.98%	↓ 1.77%

	FY23	Y/Y Change
Revenue	$1.1B	↓ 32.94%
Net Income	$99.4M	↓ 30.75%
Net Profit Margin	9.27%	↑ 0.29%

	FY24	Y/Y Change
Revenue	$602.5M	↓ 43.8%
Net Income	$2.1M	↓ 97.9%
Net Profit Margin	0.35%	↓ 8.92%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$174.7M	↓ 8.52%
Net Income	$8.3M	↑ 37.8%
Net Profit Margin	4.76%	↑ 1.6%

	Q2 FY24	Q/Q Change
Revenue	$168.6M	↓ 3.54%
Net Income	$-8.2M	↓ 198.05%
Net Profit Margin	-4.84%	↓ 9.6%

	Q3 FY24	Q/Q Change
Revenue	$140.2M	↓ 16.85%
Net Income	$1.1M	↓ 113.85%
Net Profit Margin	0.81%	↑ 5.65%

	Q4 FY24	Q/Q Change
Revenue	$119.0M	↓ 15.1%
Net Income	$800.0K	↓ 29.14%
Net Profit Margin	0.67%	↓ 0.14%

	Q1 FY25	Q/Q Change
Revenue	$115.7M	↓ 2.75%
Net Income	$-772.0K	↓ 196.5%
Net Profit Margin	-0.67%	↓ 1.34%

	Q2 FY25	Q/Q Change
Revenue	$105.6M	↓ 8.79%
Net Income	$2.5M	↓ 421.24%
Net Profit Margin	2.35%	↑ 3.02%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$536.9M	↑ 41.32%

	FY20	Y/Y Change
Profit	$697.8M	↑ 29.98%

	FY21	Y/Y Change
Profit	$1.1B	↑ 61.59%

	FY22	Y/Y Change
Profit	$1.1B	↑ 1.14%

	FY23	Y/Y Change
Profit	$775.9M	↓ 31.97%

	FY24	Y/Y Change
Profit	$444.6M	↓ 42.69%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$127.3M	↓ 9.96%

	Q2 FY24	Q/Q Change
Profit	$123.4M	↓ 3.03%

	Q3 FY24	Q/Q Change
Profit	$105.7M	↓ 14.39%

	Q4 FY24	Q/Q Change
Profit	$88.2M	↓ 16.52%

	Q1 FY25	Q/Q Change
Profit	$84.2M	↓ 4.5%

	Q2 FY25	Q/Q Change
Profit	$76.6M	↓ 9.02%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$84.3M	↑ 38.55%
Investing Cash Flow	$-6.3M	↑ 427.77%
Financing Cash Flow	$-82.3M	↑ 54.37%

	FY20	Y/Y Change
Operating Cash Flow	$145.2M	↑ 72.32%
Investing Cash Flow	$-1.3M	↓ 79.74%
Financing Cash Flow	$-57.1M	↓ 30.59%

	FY21	Y/Y Change
Operating Cash Flow	$94.5M	↓ 34.88%
Investing Cash Flow	$-29.1M	↑ 2167.08%
Financing Cash Flow	$-125.1M	↑ 118.98%

	FY22	Y/Y Change
Operating Cash Flow	$194.6M	↑ 105.8%
Investing Cash Flow	$-11.4M	↓ 60.73%
Financing Cash Flow	$-199.6M	↑ 59.5%

	FY23	Y/Y Change
Operating Cash Flow	$147.7M	↓ 24.11%
Investing Cash Flow	$-61.0M	↑ 434.84%
Financing Cash Flow	$-79.8M	↓ 60.02%

	FY24	Y/Y Change
Operating Cash Flow	$24.5M	↓ 83.42%
Investing Cash Flow	$-26.5M	↓ 56.56%
Financing Cash Flow	$-1.5M	↓ 98.1%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$7.3M	↓ 30.79%
Investing Cash Flow	$-2.8M	↓ 74.14%
Financing Cash Flow	$-1.5M	↓ 91.67%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$13.1M	↑ 79.47%
Investing Cash Flow	$-2.5M	↓ 8.76%
Financing Cash Flow	$-20.0K	↓ 98.66%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$9.1M	↓ 30.58%
Investing Cash Flow	$-1.8M	↓ 29.62%
Financing Cash Flow	$-3.0K	↓ 85.0%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$-4.9M	↓ 154.53%
Investing Cash Flow	$-19.4M	↑ 990.4%
Financing Cash Flow	$-1000.0	↓ 66.67%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$3.4M	↓ 168.85%
Investing Cash Flow	$-2.1M	↓ 89.43%
Financing Cash Flow	$-563.0K	↑ 56200.0%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$-3.4M	↓ 199.18%
Investing Cash Flow	$13.4M	↓ 750.29%
Financing Cash Flow	$-2.0K	↓ 99.64%

Medifast Technicals Summary

Sell

Neutral

Buy

Medifast is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Medifast Inc Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Medifast Inc	2.18%	0.21%	-21.68%	-88.17%	-91.54%
Frontdoor Inc	4.68%	49.55%	27.53%	165.82%	36.18%
H&r Block, Inc.	-7.56%	-6.06%	-20.08%	11.76%	244.22%
Service Corporation International	1.81%	-0.96%	1.51%	27.81%	72.9%
Bright Horizons Family Solutions Inc	-5.67%	-8.26%	-15.34%	75.53%	-14.68%
Rollins Inc.	-2.1%	6.64%	11.96%	65.49%	52.18%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Medifast Inc	42.52	42.52	1.95	-0.93	0.02	0.03	NA	21.04
Frontdoor Inc	18.03	18.03	NA	3.94	1.1	0.14	NA	3.47
H&r Block, Inc.	11.39	11.39	0.8	5.15	0.68	0.16	0.03	0.66
Service Corporation International	21.45	21.45	1.78	3.83	0.35	0.03	0.02	11.08
Bright Horizons Family Solutions Inc	38.8	38.8	1.76	4.25	0.13	0.05	NA	24.47
Rollins Inc.	55.98	55.98	4.92	1.12	0.37	0.14	0.01	2.98

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Medifast Inc	Sell	$154.2M	-91.54%	42.52	0.76%
Frontdoor Inc	Buy	$4.4B	36.18%	18.03	13.07%
H&r Block, Inc.	Buy	$6.7B	244.22%	11.39	16.11%
Service Corporation International	Buy	$11.2B	72.9%	21.45	12.6%
Bright Horizons Family Solutions Inc	Buy	$6.7B	-14.68%	38.8	6.34%
Rollins Inc.	Buy	$27.4B	52.18%	55.98	13.71%

About Medifast Inc

Medifast, Inc., through its subsidiaries, operates as a health and wellness company that provides habit-based and coach-guided lifestyle solutions to address obesity and support a healthy life in the United States. The company offers weight loss and weight management plans; and GLP-1 support plans that provide access to GLP-1 medications where clinically appropriate under the OPTAVIA brand name. It also provides bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups, as well as provides coaching support along with community, nutrition, and healthy habits, and helps people in their weight loss journey. It markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Organization	Medifast
Employees	504
CEO	Mr. Daniel R. Chard
Industry	Retail Trade

Key Management of Medifast Inc

Name	Title
Mr. Daniel R. Chard	Executive Chairman & CEO
Mr. James P. Maloney CPA	Chief Financial Officer
Mr. Anthony E. Tyree	Chief Business Operations Officer
Mr. Jason L. Groves Esq.	Executive VP, General Counsel & Corporate Secretary
Mr. Nicholas M. Johnson	Chief Field Operations Officer
Mr. Jonathan Barrett MacKenzie	VP of Finance & Chief Accounting Officer
Mr. Steven Zenker	Vice President of Investor Relations
Ms. Claudia C. Greninger	Chief Human Resources Officer

Important FAQs about investing in MED Stock from India :

What is Medifast share price today?

Medifast share price today is $14.04 as on August 30, 2025 at 1:29 am IST at the close of the market. Medifast share today touched a day high of $14.21 and a low of $14.02.

What is the 52 week high and 52 week low for Medifast share?

Medifast share touched a 52 week high of $21.98 and a 52 week low of $11.57. Medifast stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $14.04, lower by 36.12% versus the 52 week high.

How to invest in Medifast Stock (MED) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Medifast on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Medifast Shares that will get you 0.1068 shares as per Medifast share price of $14.04 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Medifast Stock (MED) from India?

Indian investors can start investing in Medifast (MED) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Medifast stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Medifast share’s latest price of $14.04 as on August 30, 2025 at 1:29 am IST, you will get 0.7123 shares of Medifast. Learn more about fractional shares .

What are the returns that Medifast has given to Indian investors in the last 5 years?

Medifast stock has given -91.54% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?